AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr

California Public Employees Retirement System lessened its stake in shares of Natera, Inc. (NASDAQ:

Fifth Third Bancorp boosted its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 3,373.1% during

Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full de

Amova Asset Management Americas Inc. reduced its position in Natera, Inc. (NASDAQ: NTRA) by 10.1% in

Stanley Druckenmiller doesn't do consensus. The Duquesne Family Office's latest 13F reveals a top-fi

Allspring Global Investments Holdings LLC grew its holdings in Natera, Inc. (NASDAQ: NTRA) by 2.0% d

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr

It may not be a familiar name, but Natera has provided better returns than Nvidia over the past 12 m

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the pr

Natera's Signatera became the first personalized MRD test for solid tumors to earn EU IVDR certifica

Morgan Stanley analyst Tejas Savant maintains Natera (NASDAQ:NTRA) with a Overweight and raises t

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks E

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr

Evercore ISI Group analyst Daniel Markowitz maintains Natera (NASDAQ:NTRA) with a Outperform and

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr

Natera's Aveta partnership brings Signatera into a global Phase 3 head and neck cancer trial to asse

Guggenheim analyst Subbu Nambi maintains Natera (NASDAQ:NTRA) with a Buy and raises the price tar

Genetic testing firm Natera and cancer drug developer Aveta Biomics said on Monday they ​have partne

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomi

AUSTIN, Texas & BEDFORD, Mass.--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cel

Bernstein analyst Eve Burstein reiterates Natera (NASDAQ:NTRA) with a Outperform and announces $310

Bernstein analyst Eve Burstein reiterates Natera (NASDAQ:NTRA) with a Outperform and announces $3

Natera's Signatera gains Japan PMDA approval for CRC, marking the country's first approved MRD test

Natera (NTRA) saw its shares surge in the last session with trading volume being higher than average

Eledon has established the regulatory framework for its Phase 3 kidney transplantation program and p

AUSTIN, Texas & IRVINE, Calif.--(BUSINESS WIRE)--Natera, Inc. (Nasdaq: NTRA), a global leader in cel

Natera Inc. (NASDAQ:NTRA) said Japan's Ministry of Health, Labour and Welfare approved its Signatera

Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target f

Barclays analyst Luke Sergott maintains Natera (NASDAQ:NTRA) with a Overweight and lowers the pri

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and pr

BTIG analyst Mark Massaro maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target f

Natera (NTRA) stock rallies following a key NCCN guideline update for Signatera. Also, check out the

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced

Tom Lee's GRNJ added First Solar, Zoom and eight other stocks in its latest rebalance as assets

Natera rises after a Delaware court grants a 30% ongoing royalty in its MRD patent battle with Arche

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a propos

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday afte

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% o